These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 4257195)

  • 21. [Effect of prolonged cold exposure on monoamine oxidase activity and kinetics and on serotonin metabolism in the rat brain].
    Molodtsova GF
    Biull Eksp Biol Med; 1983 Sep; 96(9):16-8. PubMed ID: 6193823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Some derivatives of 3-amino-2-oxazolidinone influencing neurotransmission of dopamine and serotonin.
    Chilmonczyk Z; Krzywda J; Cybulski J; Iskra-Jopa J
    Pharmazie; 1997 Feb; 52(2):152-7. PubMed ID: 9122275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE; Nichols DE
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-monoamine-oxidase activity of some beta-acyl-phenylhydrazines].
    Arrigo Reina R; Mazzone G
    Boll Soc Ital Biol Sper; 1970 Dec; 46(24):1041-4. PubMed ID: 5519865
    [No Abstract]   [Full Text] [Related]  

  • 26. [Kinetic study of monoamine oxidase activity of rat liver mitochondria].
    Coq H; Baron C
    Bull Soc Chim Biol (Paris); 1968 Mar; 50(1):163-78. PubMed ID: 5639280
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of peripheral serotonin antagonists and monoamine oxidase inhibitors on some central effects of indolalkylamines].
    Gilev AP; Tetenchuk EV
    Farmakol Toksikol; 1968; 31(2):159-63. PubMed ID: 5674667
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhibition by monoamine oxidase inhibitors of substrate induction of liver tryptophan pyrrolase and increase in brain serotonin].
    Samsonova ML; Oksenkrug GF
    Vopr Med Khim; 1972; 18(2):198-202. PubMed ID: 4679586
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibition.
    Grahame-Smith DG; Green AR
    Br J Pharmacol; 1974 Mar; 50(3):443P-446P. PubMed ID: 4277620
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 31. Pineal gland in organ culture. I. Inhibition by harmine of serotonin-14C oxidation, accompanied by stimulation of melatonin-14C production.
    Klein DC; Rowe J
    Mol Pharmacol; 1970 Mar; 6(2):164-71. PubMed ID: 5418234
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of short-term hypothermia on the monoamine oxidase system in the rat brain].
    Molodtsova GF
    Vopr Med Khim; 1982; 28(5):36-40. PubMed ID: 6184883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antidepressant agents. 3. Aza-analogues of etryptamine.
    Carnmalm B; Misiorny A; Ross SB; Stjernström NE
    Acta Pharm Suec; 1974 May; 11(2):196-200. PubMed ID: 4418846
    [No Abstract]   [Full Text] [Related]  

  • 34. [Central effects of betamezide].
    Mikhaĭlova TV; Gilev AP; Khavronina-Gureeva ZP
    Farmakol Toksikol; 1969; 32(6):652-6. PubMed ID: 5381593
    [No Abstract]   [Full Text] [Related]  

  • 35. The disappearance of serotonin by monoamine oxidase inhibitor insensitive agent in rat liver homogenate.
    Nagatsu T; Yagi K
    J Biochem; 1965 Sep; 58(3):302-4. PubMed ID: 5861338
    [No Abstract]   [Full Text] [Related]  

  • 36. The effects of drugs on serotonergic nerve terminals.
    Bloom FE; Costa E
    Adv Cytopharmacol; 1971 May; 1():379-95. PubMed ID: 5163249
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of a monoamine oxidase inhibitor on blood ammonia and gastric secretion in dogs: II. Dogs with side-to-side and end-to-side portacaval anastomosis.
    Kowalewski K; Bondar GF
    Can J Surg; 1966 Jan; 9(1):99-103. PubMed ID: 5900272
    [No Abstract]   [Full Text] [Related]  

  • 38. [Monoamines and manic-depressive syndromes].
    Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1967; 100(2):487-98. PubMed ID: 4873952
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of iprazid on serotonin inactivation by lung tissue].
    Dubileĭ PV
    Farmakol Toksikol; 1978; 41(2):164-7. PubMed ID: 658359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What does the 5-hydroxyindolacetic acid excretion in human urine indicate about serotonin metabolism and the efficacy of drugs interfering with this metabolism?].
    Degkwitz R
    Klin Wochenschr; 1965 Aug; 43(16):887-92. PubMed ID: 5862692
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.